Rockwell Medical names iron-delivery drug Triferic; U. of Nebraska picks up $11.2 grant for nanotech delivery;

@MichaelGFierce: Special report: The race for the artificial pancreas. Report | Follow @MichaelGFierce

> Rockwell Medical now has a name for its investigational iron-delivery drug: Triferic. The FDA accepted the proposed trade name for the previously monickered soluble ferric pyrophosphate. Release

> The University of Nebraska Medical Center has been awarded a grant of more than $11.2 million from the National Institute of General Medical Sciences for its efforts in the areas of drug delivery and nanomedicine. News

> Researchers at The Rockefeller University have developed a new technique by which RNA interference can find genes that cause tumor growth in mice. Report

> Iranian scientists have created multi-layer titania nanotube arrays that can be used in targeted drug delivery. More

> Medgenics ($MEDG) said goodbye to Andrew Pearlman, who retired from his position as CEO, and the company appointed Michael Cola as the new president and chief. Release

Suggested Articles

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.